Gts Securities LLC Moderna, Inc. Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$63.64 - $125.14 $1.89 Million - $3.72 Million	29,700 Added 16.48%	209,900 $14 Million
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $2.6 Million - $4.28 Million	25,700 Added 16.63%	180,200 $21.4 Million
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $13.9 Million - $18.9 Million	-163,400 Reduced 51.4%	154,500 $16.5 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $2.8 Million - $4.21 Million	40,300 Added 14.52%	317,900 $31.6 Million
Q3 2023 Nov 15, 2023	BUY	$96.41 - $126.61 $26.8 Million - $35.1 Million	277,600 New	277,600 $28.7 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.